| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |